Indivior ( (GB:INDV) ) has shared an announcement.
Indivior PLC announced a significant change in its shareholder structure as Morgan Stanley’s total applicable holding in the company dropped below the 5% threshold, triggering a notification obligation. As a result, Morgan Stanley applied the trading book exemption to its remaining applicable holding of 4.979353% as of February 25, 2025. This development may impact Indivior’s market perception and investor confidence, as changes in major holdings can influence stakeholder sentiment and the company’s strategic direction.
More about Indivior
Indivior PLC is a UK-based pharmaceutical company specializing in the development and marketing of medications for the treatment of addiction and related mental health disorders. The company focuses on providing innovative treatment solutions to address the unmet needs of patients suffering from opioid use disorder and other addiction-related conditions.
YTD Price Performance: -36.43%
Average Trading Volume: 302,050
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £810.1M
For an in-depth examination of INDV stock, go to TipRanks’ Stock Analysis page.